Day 2 (31 July 2024)
31 July 2024 (Tues) | 08:00 - 18:30
Day 2 Programme
31 Jul | 08:00 - 09:00
Registration
31 Jul | 09:00 - 10:30
Track 5: Adaptive Trial Design (Complex Clinical Trial Design)
"Lessons Learned and Best Practices – Adaptive Trial Design"
Delve into the lessons learned and best practices in navigating complex trial design for clinical trials. This session will discuss how adaptive clinical trial designs can enhance efficiency in clinical research.
Director, Infectious Disease Research and Training Office, National Centre for Infectious Disease (NCID)
Deputy Executive Director, Programme for Research in Epidemic Preparedness and Response (PREPARE)
Professor, Lee Kong Chian School of Medicine, NTU & NUS Yong Loo Lin School of Medicine
Biostatistician
Telethon Kids Institute and University of Western Australia Medical School
31 Jul | 09:00 - 10:30
Track 6: Trends in Clinical Trials
"Unveiling Diverse Clinical Trial Landscapes Across Countries"
This session will map out the diverse range of clinical trial trends and practices internationally, as well explore ways to improve collaboration across borders to advance clinical research for better health outcomes.
Acting Director, National Biomedical Genome and Science Institute
Ministry of Health, Indonesia
CEO, University of Hong Kong Clinical Trials Centre (China)
Managing Director, University of Hong Kong Clinical Trials Centre (China)
Honorary Assistant Professor, Macau University of Science and Technology
31 Jul | 10:30 - 11:00
Tea Break
31 Jul | 11:00 - 12:30 GMT+8
Track 7: Biotech Sharing Session
"Challenges and Opportunities For Biotechs to Conduct Clinical Trials in Singapore"
Biotech companies play an increasingly important role in therapeutics development in Singapore. This session will explore the unique challenges and opportunities faced by biotech companies conducting clinical trials in Singapore. From regulatory considerations to infrastructure development and funding, hear from speakers on how they are navigating the local clinical trial landscape.
Deputy CEO (Strategic Partnerships), National Cancer Centre, Singapore (NCCS)
Professor, Duke-NUS Medical School
31 Jul | 11:00 - 12:30
Track 8: Talent Development in Clinical Trials
"Nurturing Excellence: Advancing Talents in Clinical Research"
This session will explore the significance of guiding emerging clinician scientists through mentorship, the essential functions fulfilled by clinical research coordinators (CRCs), and the pivotal role of a collaborative partnership between clinician scientists and CRCs in ensuring the efficient management of clinical trials. 
Manager, Research Office - Clinical Trials & Research Unit (CTRU)
Changi General Hospital
Head (Cancer Genetics Service) & Senior Consultant (Division of Medical Oncology), National Cancer Centre Singapore
Associate Professor (Genomic Medicine), Lee Kong Chian School of Medicine, Nanyang Technological University
31 Jul | 12:30 - 14:00
Lunch & Networking
31 Jul | 14:00 - 15:30
Track 9: Data Governance in Clinical Research
"Advancing Clinical Research Through Effective Data Governance: Strategies, Challenges, and Innovations"
Data is fundamental for research. However, there are concerns around access, security, integrity and ethical use of data in research. In this session, we seek to understand the principles of governance and access to Singapore’s research data.
31 Jul | 15:30 - 17:00
Track 10: Data Powered Research
"Innovations in Data-Driven Research: Shaping Tomorrow's Discoveries"
In a digital age, data-powered research is driving innovation and shaping future discoveries. Gain insights into the latest advancements in leveraging data to unlock new possibilities to advance research and transform healthcare.
CEO & Senior Consultant, National Heart Centre Singapore (NHCS)
Deputy Group Chief Medical Informatics Officer (Research), SingHealth
31 Jul | 17:15 - 18:30
Networking Session
31 Jul | 18:30
End of Day 2
*Please note that the programme may be subject to change without prior notice.
Tracks 1-10 will comprise of a 45-min presentation by speakers followed by 45-min panel discussion.